Finance

Lists
U2TH34:BVMF
United Therapeutics Corp Bdr
R$129.50
0.00%
(0.00) 1D
Aug 14, 10:47:14 AM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for U2TH34...
Mkt. cap
22.01B
Avg. vol.
0.00
Volume
0.00
52-wk high
R$155.07
52-wk low
R$105.71
Shares outstanding
42.89M
No. of employees
1K
Mkt. cap
22.01B
Avg. vol.
0.00
Volume
0.00
52-wk high
R$155.07
52-wk low
R$105.71
Shares outstanding
42.89M
No. of employees
1K
News stories
From web sources and news partners
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp Bdr
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorBiotechnology
Websiteunither.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
799.50M
790.20M
781.50M
783.30M
Cost of goods sold
100.90M
103.40M
133.40M
99.50M
Cost of revenue
100.90M
103.40M
133.40M
99.50M
Research and development expenses
127.50M
139.50M
138.20M
146.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
181.80M
189.90M
184.10M
206.70M
Operating expense
309.30M
329.40M
322.30M
353.00M
Total operating expenses
410.20M
432.80M
455.70M
452.50M
Operating income
389.30M
357.40M
325.80M
330.80M
Other non operating income
300.00K
800.00K
15.30M
-100.00K
EBT including unusual items
438.00M
444.00M
318.30M
372.70M
EBT excluding unusual items
433.00M
398.30M
379.90M
359.30M
Income tax expense
99.30M
79.70M
43.40M
39.70M
Effective tax rate
22.67%
17.95%
13.63%
10.65%
Other operating expenses
-
-
-
-
Net income
338.70M
364.30M
274.90M
333.00M
Net profit margin
42.36%
46.10%
35.18%
42.51%
Earnings per share
7.16
7.70
5.82
7.27
Interest and investment income
46.40M
43.20M
41.80M
31.50M
Interest expense
-3.00M
-3.10M
-3.00M
-2.90M
Net interest expenses
43.40M
40.10M
38.80M
28.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
411.20M
380.20M
348.40M
355.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps